Imagine losing your child to cancer because her symptoms were dismissed simply because she was young. This heartbreaking reality is what Mark and Michelle Sneddon faced when their 17-year-old daughter, Isla, passed away in March 2025, just six months after being diagnosed with breast cancer. But here’s where it gets controversial: they believe Isla’s life could have been saved if she had been treated with the same urgency as an adult. And this is the part most people miss—age-based biases in medical referrals can have deadly consequences.
Isla’s journey began in July 2022 when she visited her GP with a lump in her breast. She was told it was likely benign, attributed to hormonal changes, and that she would ‘grow out of it.’ Fast forward two years, and Isla’s condition worsened, leading to an urgent referral for biopsies. But here’s the shocking twist: the referral was downgraded to routine because of her age, delaying her diagnosis until the cancer had spread to her lungs, lymph nodes, and the lining of her heart. By September 2024, she was given just six months to a year to live.
Despite chemotherapy, Isla’s health deteriorated rapidly. Her parents recall being told she was the ‘sickest person in the hospital,’ yet they clung to hope. Sadly, Isla passed away in their arms in March 2025. Her parents are now advocating for Isla’s Law, a campaign to ensure children and young people in Scotland receive the same urgent care and diagnostic access as adults. But here’s the question that sparks debate: Are current medical guidelines failing young patients by underestimating the severity of their symptoms?
Michelle Sneddon highlights how Isla’s symptoms were often dismissed as anxiety due to her age. Later, it was revealed that these were actually signs of cancer. She argues that if a child presents with multiple symptoms like lumps, chest infections, or tonsillitis, GPs should deviate from standard guidelines and explore alternative pathways. And this is the part that’s rarely discussed: rare cancers like Isla’s often don’t fit neatly into existing protocols, leaving young patients at risk.
NHS Lanarkshire has expressed sympathy and assured the family that Isla’s treatment followed clinical pathways. However, Mark and Michelle remain determined to prevent other families from enduring similar heartbreak. They’re set to meet with Health Secretary Neil Gray, though they’ve been told legislative changes may await a new government. But here’s the bigger question: How many more lives will be lost before systemic changes are made?
This story isn’t just about Isla—it’s a call to action. Are we doing enough to protect young patients? Share your thoughts in the comments—let’s keep this conversation going.
